Osteoblastic bone metastases from renal cell carcinoma

1. McLaughlin JK, Lipworth L. Epidemiologic aspects of renal cell cancer. Semin Oncol 2000; 27: 115-23.Search in Google Scholar

2. Patard JJ, Kim HL, Lam JS, Dorey FJ, Pantuck AJ, Zisman A, et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 2004; 22: 3316-22.10.1200/JCO.2004.09.10415310775Search in Google Scholar

3. Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, et al. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am 2007; 89: 1794-1801.10.2106/00004623-200708000-00018Search in Google Scholar

4. Forbes GS, McLeod RA, Hattery RR. Radiographic manifestations of bone metastases from renal carcinoma. AJR Am J Roentgenol 1977; 129: 61-6.10.2214/ajr.129.1.61409145Search in Google Scholar

5. Reidy JF. Osteoblastic metastases from a hypernephroma. Br J Radiol 1975; 48: 225-7.10.1259/0007-1285-48-567-2251125551Search in Google Scholar

6. Neugut AI, Casper ES, Godwin TA, Smith J. Osteoblastic metastases in renal cell carcinoma. Br J Radiol 1981; 54: 1002-4.10.1259/0007-1285-54-647-10027306758Search in Google Scholar

7. Liu PT, Conley CR, Callstrom MR. Sclerotic bone metastases from sarcomatoid renal cell carcinoma. Skeletal Radiol 1999; 28: 590.10.1007/s00256005062510550538Search in Google Scholar

8. Sneag DB, Krajewski KM, Howard S, Jagannathan JP, Star KV, Ramaiya N. Sclerotic osseous metastases from renal cell carcinoma. Skeletal Radiol 2012; 41: 1169-75.10.1007/s00256-012-1424-322576970Search in Google Scholar

9. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001; 27: 165-76.10.1053/ctrv.2000.021011417967Search in Google Scholar

10. Shinagare AB, Fennessy FM, Ramaiya NH, Jagannathan JP, Taplin ME, van den Abbeele AD. Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location. J Comput Assist Tomogr 2011; 35: 217-22.10.1097/RCT.0b013e31820d7a3721412093Search in Google Scholar

11. Bhat S. Role of surgery in advanced/metastatic renal cell carcinoma. Indian J Urol 2010; 26: 167-76.10.4103/0970-1591.65381293853720877591Search in Google Scholar

12. Toyoda Y, Shinohara N, Harabayashi T, Abe T, Akino T, Sazawa A et al. Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol 2007; 52: 163-8.10.1016/j.eururo.2006.10.06017098353Search in Google Scholar

13. Keegan KA, Schupp CW, Chamie K, Hellenthal NJ, Evans CP, Koppie TM. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol 2012; 188: 391-7.10.1016/j.juro.2012.04.006371440022698625Search in Google Scholar

14. Rosenberg SA, Yang JC, White DE. Durability of complete response in patients with metastatic cancer treatment with high dose IL2 identification of the antigen mediating response. Ann Surg 1998; 229: 307-19.10.1097/00000658-199809000-0000411914839742914Search in Google Scholar

15. Divgi CR, Uzzo RG, Gatsonis C, Bartz R, Treutner S, Yu JQ, et al. Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. J Clin Oncol 2013; 31: 187-94.10.1200/JCO.2011.41.2445579566323213092Search in Google Scholar

16. Rajer M. Kidney cancer. Radiol Oncol 2007; 41: 64-71.10.2478/v10019-007-0012-ySearch in Google Scholar